PERIOPERATIVE ADVERSE OUTCOMES IN PATIENTS WITH ATRIAL FIBRILLATION TAKING EDOXABAN OR WARFARIN: ANALYSIS OF THE ENGAGE AF-TIMI 48 TRIAL

PERIOPERATIVE ADVERSE OUTCOMES IN PATIENTS WITH ATRIAL FIBRILLATION TAKING EDOXABAN OR WARFARIN: ANALYSIS OF THE ENGAGE AF-TIMI 48 TRIAL

Methods: We studied consecutive patients in ENGAGE, a randomized double-blind trial comparing edoxaban (30 and 60 mg QD) with warfarin for stroke prevention in AF, who had a first surgery/procedure.

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of the American College of Cardiology 2015-03, Vol.65 (10), p.A2092-A2092
Hauptverfasser: Douketis, James, Weitz, Jeffrey, Murphy, Sabina, Deenadayalu, Naveen, Crompton, Andrea Elizabeth, Mercuri, Michele, Ruff, Christian, Antman, Elliott, Giugliano, Robert
Format: Artikel
Sprache:eng
Schlagworte:
Anticoagulants
Cardiac arrhythmia
Cardiology
Cardiovascular
Drug therapy
Internal Medicine
Surgery
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Methods: We studied consecutive patients in ENGAGE, a randomized double-blind trial comparing edoxaban (30 and 60 mg QD) with warfarin for stroke prevention in AF, who had a first surgery/procedure.
ISSN:0735-1097
1558-3597
DOI:10.1016/S0735-1097(15)62092-7